Experience with second allogeneic hematopoietic stem cell transplantation in Chilean patients: A single-center study Yorman Flores; Javier Díaz; Patricio Rojas; José Salinas; Catherine Gutiérrez; Marcela Vidal; Verónica Jara; Elizabeth Rivera; María José García; Vicente Sandoval; Felipe Palacios; Maximiliano Vergara; Mauricio Ocqueteau; Mauricio Sarmiento;

BLINATUMOMAB BRIDGING THERAPY FOR EFFECTIVE MANAGEMENT OF MRD IN PRO-B ALL WITH CNS INVOLVEMENT: A CASE REPORT OF POST TRANSPLANT PATIENT AT 23 MONTHS AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION Ceren Dehri Bah¿i; Birol Güvenç;

Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country Chantiya Chanswangphuwana; Kitsada Wudhikarn; Phandee Watanaboonyongcharoen; Patsita Kansuwan; Autcharaporn Sukperm; Udomsak Bunworasate;